My generation prefers to trust the hive mind to the health system when it comes to caring for our bodies and minds. The ...
Pharnext has been testing PXT3003 (a fixed-dose combination of baclofen, naltrexone and sorbitol) in the pivotal PREMIER trial, which recruited a subgroup of patients with type 1 CMT, the most ...